Evaluation Of The Efficacy Of Antiaggregant Therapy In Covid-19
DOI:
https://doi.org/10.64149/J.Ver.8.20s.129-134Keywords:
Coronavirus Infection, Platelet Activity, Coagulation Hemostasis, Platelet Aggrega-tion, Platelet Adhesion, Acetylsalicylic Acid, Clopidogrel.Abstract
In patients with mild coronavirus infection, platelet activity and coagulation he-mostasis did not show significant changes. However, in moderate and severe cas-es, platelet aggregation and adhesion activity increased. When platelet aggregation and adhesion activity increased, treatment with a combination of acetylsalicylic ac-id and 75 mg of clopidogrel, compared to standard therapy, provided the most ef-fective correction of hemostatic changes.
Downloads
Published
2025-12-23
Issue
Section
Articles
How to Cite
Evaluation Of The Efficacy Of Antiaggregant Therapy In Covid-19. (2025). Vascular and Endovascular Review, 8(20s), 129-134. https://doi.org/10.64149/J.Ver.8.20s.129-134



